Acorda Therapeutics Company Profile (NASDAQ:ACOR)

About Acorda Therapeutics

Acorda Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in the identification, development and commercialization of therapies that restore function and recovers the lives of people with neurological disorders. Its commercial products include Ampyra, Fampyra, Zanaflex Capsules and a generic version of the capsules, Zanaflex tablets and Qutenza. Its research and development programs include CVT-301, Dalfampridine, Plumiaz, Neuregulin Program, Remyelinating Antibodies Program, CVT-427 and Chondroitinase Program. Its Ampyra is an oral drug for the treatment to improve walking in patients with multiple sclerosis. Zanaflex Capsules and tablets are used as short-acting drugs for the management of spasticity. Qutenza is a dermal patch for the management of neuropathic pain associated with post-herpetic neuralgia. Its pipeline of neurological therapies addresses a range of disorders, including Parkinson's disease, chronic post-stroke walking deficits and migraine.

Industry, Sector and Symbol:

• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Exchange: NASDAQ
• Symbol: ACOR
• CUSIP: 00484M10

Key Metrics:

• Previous Close: $20.64
• 50 Day Moving Average: $24.68
• 200 Day Moving Average: $26.07
• 52-Week Range: $20.51 - $43.63
• Trailing P/E Ratio: N/A
• Foreward P/E Ratio: 30.71
• P/E Growth: 1.62
• Market Cap: $964.20M
• Outstanding Shares: 46,090,000
• Beta: 1.46

Profitability:

• Net Margins: -1.08%
• Return on Equity: 1.00%
• Return on Assets: 0.53%

Debt:

• Debt-to-Equity Ratio: 0.43%
• Current Ratio: 1.93%
• Quick Ratio: 1.53%

Additional Links:

• Visit Acorda Therapeutics' Official Website
• View ACOR on Google Finance
• View ACOR on Yahoo Finance
• View ACOR's Company Profile on Reuters
• Search for Acorda Therapeutics Inc. on Google

Companies Related to Acorda Therapeutics:

• Lexicon Pharmaceuticals (NASDAQ:LXRX)
• HMS Holdings Corp. (NASDAQ:HMSY)
• Haemonetics Corp. (NYSE:HAE)
• Spark Therapeutics (NASDAQ:ONCE)
• Exact Sciences Corp. (NASDAQ:EXAS)
• The Advisory Board (NASDAQ:ABCO)
• Select Medical Holdings Corp. (NYSE:SEM)
• Theravance Biopharma (NASDAQ:TBPH)
• Impax Laboratories (NASDAQ:IPXL)
• DBV Technologies SA - (NASDAQ:DBVT)

Earnings

Earnings History for Acorda Therapeutics (NASDAQ:ACOR)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call	Details
10/20/2016
7/28/2016	Q216	$0.18	$0.07	$128.33 million	$127.45 million	View	Listen
4/28/2016	Q116	$0.08	$0.07	$115.36 million	$115.90 million	View	Listen
2/11/2016	Q415	$0.22	$0.28	$128.24 million	$130.90 million	View	Listen
10/22/2015	Q315	$0.15	$0.31	$115.52 million	$148.20 million	View	Listen
7/30/2015	Q215	$0.17	$0.31	$110.84 million	$113.70 million	View	Listen
4/30/2015	Q115	$0.03	($0.02)	$100.20 million	$99.85 million	View	N/A
2/12/2015	Q414	$0.14	$0.46	$110.80 million	$117.90 million	View	N/A
10/30/2014	Q314	$0.05	$0.28	$94.70 million	$106.00 million	View	N/A
7/31/2014	Q214	$0.15	$0.42	$91.40 million	$97.13 million	View	N/A
5/6/2014	Q114	$0.09	$0.21	$81.30 million	$80.52 million	View	N/A
2/19/2014	Q413	$0.18	$0.32	$89.96 million	$92.59 million	View	N/A
10/31/2013	Q313	$0.13	$0.36	$90.01 million	$84.92 million	View	Listen
8/1/2013	Q2 2013	$0.09	$0.25	$82.57 million	$87.05 million	View	Listen
5/2/2013	Q1 2013	$0.20	$0.09	$80.77 million	$71.90 million	View	Listen
2/13/2013	Q4 2012	$0.15	$0.24	$78.90 million	$81.47 million	View	Listen
10/31/2012	Q312	$0.10	$0.38	$75.20 million	$77.44 million	View	N/A
7/31/2012		$0.27	$0.27			View	N/A
5/3/2012		$0.27	$0.36			View	N/A
2/16/2012		$0.24	$0.40			View	N/A
11/4/2011		$0.82	$0.47			View	N/A
8/1/2011		$0.10	$0.01			View	N/A
5/5/2011		$0.17	($0.02)			View	N/A
2/17/2011		$0.17	$0.09			View	N/A

(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Acorda Therapeutics (NASDAQ:ACOR)

Dividends

Dividend History for Acorda Therapeutics (NASDAQ:ACOR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Acorda Therapeutics (NASDAQ:ACOR)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
9/23/2016	Jane Wasman	Insider	Sell	500	$27.32	$13,660.00
6/22/2016	David Lawrence	Insider	Sell	500	$25.09	$12,545.00
6/8/2016	Steven M Rauscher	Director	Sell	1,086	$27.83	$30,223.38
5/13/2016	Andrew A Hindman	Insider	Sell	4,860	$26.11	$126,894.60
4/19/2016	Lorin Randall	Director	Sell	1,488	$28.68	$42,675.84
1/4/2016	Ian F. Smith	Director	Sell	13,231	$41.85	$553,717.35
12/23/2015	Jane Wasman	insider	Sell	10,751	$43.10	$463,368.10
12/22/2015	Lauren M. Sabella	insider	Sell	7,113	$42.04	$299,030.52
12/21/2015	Jane Wasman	Insider	Sell	817	$42.00	$34,314.00
12/18/2015	David Lawrence	insider	Sell	39,026	$40.63	$1,585,626.38
12/17/2015	Lauren M. Sabella	insider	Sell	14,229	$40.00	$569,160.00
12/1/2015	Enrique J Carrazana	Insider	Sell	7,218	$38.08	$274,861.44
12/1/2015	Ron Cohen	CEO	Sell	11,850	$38.08	$451,248.00
10/19/2015	Andrew Blight	insider	Sell	32,500	$30.87	$1,003,275.00
10/7/2015	Michael W. Rogers	CFO	Sell	5,700	$30.24	$172,368.00
10/5/2015	Jane Wasman	insider	Sell	3,750	$31.75	$119,062.50
10/5/2015	Ron Cohen	CEO	Sell	135,000	$28.03	$3,784,050.00
9/21/2015	Andrew Blight	insider	Sell	13,085	$31.30	$409,560.50
5/15/2015	Andrew A Hindman	Insider	Sell	4,779	$29.82	$142,509.78
1/12/2015	Enrique J Carrazana	Insider	Sell	97,993	$42.21	$4,136,284.53
12/18/2014	David Lawrence	Insider	Sell	27,109	$40.11	$1,087,341.99
12/18/2014	John P Kelley	Director	Sell	10,000	$40.00	$400,000.00
12/1/2014	David Lawrence	Insider	Sell	8,898	$35.60	$316,768.80
12/1/2014	Lauren M Sabella	VP	Sell	3,242	$35.58	$115,350.36
12/1/2014	Michael W Rogers	CFO	Sell	230	$35.58	$8,183.40
12/1/2014	Ron Cohen	CEO	Sell	34,394	$35.59	$1,224,082.46
10/7/2014	Michael W Rogers	CFO	Sell	5,700	$33.10	$188,670.00
10/3/2014	Jane Wasman	Insider	Sell	3,750	$34.13	$127,987.50
9/24/2014	Jane Wasman	Insider	Sell	14,923	$36.00	$537,228.00
8/27/2014	Jane Wasman	Insider	Sell	14,923	$33.00	$492,459.00
12/5/2013	Lauren Sabella	VP	Sell	8,797	$31.81	$279,832.57
12/2/2013	Enrique Carrazana	Insider	Sell	1,640	$33.56	$55,038.40
10/15/2013	Enrique J Carrazana	Insider	Sell	3,333	$32.38	$107,922.54
10/3/2013	Jane Wasman	Insider	Sell	3,750	$35.74	$134,025.00
8/20/2013	Ron Cohen	CEO	Sell	149,000	$34.10	$5,080,900.00
8/2/2013	John Kelley	Director	Sell	15,000	$38.00	$570,000.00
7/19/2013	Andrew Blight	Insider	Sell	19,296	$37.82	$729,774.72
6/10/2013	Ron Cohen	CEO	Sell	11,000	$34.15	$375,650.00
5/8/2013	Sandra Phd Panem	Director	Sell	10,000	$33.80	$338,000.00
12/4/2012	Lauren M Sabella	VP	Sell	4,364	$24.58	$107,267.12
12/3/2012	Andrew Blight	Insider	Sell	7,200	$24.20	$174,240.00
12/3/2012	David Lawrence	CFO	Sell	9,313	$24.21	$225,467.73
12/3/2012	Ron Cohen	CEO	Sell	16,407	$24.22	$397,377.54
11/13/2012	Sandra Phd Panem	Director	Sell	22,569	$24.12	$544,364.28

(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Acorda Therapeutics (NASDAQ:ACOR)

Date	Headline
	Acorda Therapeutics, Inc. Gains Title To All Shares In Biotie Therapies Corp. And The Shares Will Delist From Nasdaq Helsinki (NASDAQ:ACOR) www.publicnow.com - September 30 at 3:28 PM
	Acorda Therapeutics, Inc. (NASDAQ:ACOR) Updated Broker Price Targets - The De Soto Edge (NASDAQ:ACOR) desotoedge.com - September 30 at 8:03 AM
	ACORDA GAINS TITLE TO BIOTIE SHARES AND THE SHARES WILL DELIST (NASDAQ:ACOR) finance.yahoo.com - September 30 at 8:02 AM
	Acorda Therapeutics: New 52-Week Low Set Today (ACOR) (NASDAQ:ACOR) www.mysmartrend.com - September 29 at 3:15 PM
	Latest Analyst Reports On Acorda Therapeutics, Inc. - NewsDen (NASDAQ:ACOR) newsden.net - September 28 at 8:03 AM
	The Arbitral Tribunal Has Confirmed Acorda Therapeutics, Inc.'s Redemption Right Regarding the Shares in Biotie Therapies Corp. And Public Trading in The Shares Has Been Terminated (NASDAQ:ACOR) www.publicnow.com - September 28 at 8:03 AM
	Traders Alert - General Electric Company, (NYSE:GE), Acorda Therapeutics, (NASDAQ:ACOR) - Financial Breaking News (NASDAQ:ACOR) wsbreakingnews.com - September 27 at 3:17 PM
	Eye-Catching Stocks: Juniper Networks, Inc. (NYSE:JNPR), Acorda Therapeutics Inc (NASDAQ:ACOR) - NYSE Journal (press release) (NASDAQ:ACOR) stockznews.com - September 27 at 3:17 PM
	Acorda Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ACOR-US : September 27, 2016 (NASDAQ:ACOR) www.capitalcube.com - September 27 at 3:17 PM
	Monday Market Wrap: Stocks Fall Nearly 1% To Start Week - Benzinga (NASDAQ:ACOR) www.benzinga.com - September 27 at 7:22 AM
	Mid-Day Market Update: Crude Oil Up 3.3%; Chemtura Shares Surge Following Acquisition News - Benzinga (NASDAQ:ACOR) www.benzinga.com - September 26 at 3:16 PM
	ARBITRAL TRIBUNAL CONFIRMED ACORDA'S REDEMPTION RIGHT REGARDING BIOTIE SHARES AND BIOTIE ... - GlobeNewswire (press release) (NASDAQ:ACOR) globenewswire.com - September 26 at 8:31 AM
	Analysts Take the Wheel on Acorda Therapeutics, Inc. (NASDAQ:ACOR) Shares and Where They Might Be Headed - Frisco Fastball (NASDAQ:ACOR) friscofastball.com - September 21 at 10:58 AM
	Discover the Asia Pacific rna-based therapeutics market 2016: industry demand, segment, statistics and research to 2021 (NASDAQ:ACOR) www.whatech.com - September 19 at 8:04 AM
	Acorda Launches “The Many Faces of OFF” Facebook Page to ... - Business Wire (press release) (NASDAQ:ACOR) www.businesswire.com - September 15 at 3:16 PM
	Acorda Launches The Many Faces of OFF Facebook Page to Support Parkinsons Community (NASDAQ:ACOR) www.cbs58.com - September 15 at 12:08 PM
	Acorda Launches “The Many Faces of OFF” Facebook Page to Support Parkinson’s Community (NASDAQ:ACOR) www.publicnow.com - September 15 at 12:08 PM
	Takeda Says 2nd Circ. Zanaflex Ruling Torpedoes Actos Row (NASDAQ:ACOR) www.law360.com - September 14 at 8:34 PM
	Acorda Therapeutics, Inc. – Value Analysis (NASDAQ:ACOR) : September 14, 2016 (NASDAQ:ACOR) www.capitalcube.com - September 14 at 3:17 PM
	Acorda Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : ACOR-US : September 13, 2016 (NASDAQ:ACOR) www.capitalcube.com - September 13 at 3:17 PM
	Placing Acorda Therapeutics, Inc. (NASDAQ:ACOR) Shares Under the Microscope (NASDAQ:ACOR) www.nationaldailypress.com - September 9 at 3:16 PM
	What is the Sell-side Saying About Acorda Therapeutics, Inc. (NASDAQ:ACOR)? - Frisco Fastball (NASDAQ:ACOR) friscofastball.com - September 9 at 8:04 AM
	Placing Acorda Therapeutics, Inc. (NASDAQ:ACOR) Shares Under the Microscope - National Daily Press (NASDAQ:ACOR) www.nationaldailypress.com - September 9 at 8:04 AM
	Pain Management Market (Abuse Deterrent Era) - US Opioids Market is $8B in Size and of Which Extended Release Formulations Contribute 50% (NASDAQ:ACOR) www.prnewswire.co.in - September 8 at 3:16 PM
	Noteworthy Thursday Option Activity: IONS, ACOR, MON (NASDAQ:ACOR) www.forbes.com - September 8 at 3:16 PM
	ETF’s with exposure to Acorda Therapeutics, Inc. : September 6, 2016 (NASDAQ:ACOR) www.capitalcube.com - September 6 at 3:16 PM
	Stock in Review: Taking a Closer Look at Acorda Therapeutics, Inc. (NASDAQ:ACOR) Shares - Post News (NASDAQ:ACOR) www.kentuckypostnews.com - September 2 at 3:19 PM
	Shares Slipping Lower Over the Past Month: Acorda Therapeutics, Inc. (NASDAQ:ACOR) - Post News (NASDAQ:ACOR) www.kentuckypostnews.com - September 1 at 3:16 PM
	Why Does The Smart Money Like Acorda Therapeutics? - Insider Monkey (blog) (NASDAQ:ACOR) www.insidermonkey.com - August 31 at 3:17 PM
	Why Does The Smart Money Like Acorda Therapeutics? (NASDAQ:ACOR) feedproxy.google.com - August 31 at 12:54 PM
	The Listing Committee Of Nasdaq Helsinki Has Resolved To Delist The Shares Of Biotie (NASDAQ:ACOR) www.biospace.com - August 27 at 8:04 AM
	Biotie: BTT1023 receives Orphan Drug Designation in the United States (NASDAQ:ACOR) inpublic.globenewswire.com - August 26 at 11:23 AM
	Notable Thursday Option Activity: ACOR, PG, SFL (NASDAQ:ACOR) www.nasdaq.com - August 26 at 11:23 AM
	Biotie Therapies : THE LISTING COMMITTEE OF NASDAQ HELSINKI HAS RESOLVED TO DELIST THE SHARES OF BIOTIE THERAPIES CORP. (NASDAQ:ACOR) www.4-traders.com - August 26 at 11:23 AM
	7:32 am Acorda Therapeutics' Biotie confirms it was granted orphan designation by the FDA for BTT1023 for the treatment of primary sclerosing cholangitis (NASDAQ:ACOR) finance.yahoo.com - August 26 at 11:23 AM
	ETF’s with exposure to Acorda Therapeutics, Inc. : August 26, 2016 (NASDAQ:ACOR) www.capitalcube.com - August 26 at 11:23 AM
	Acorda Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ACOR-US : August 25, 2016 (NASDAQ:ACOR) www.capitalcube.com - August 25 at 3:16 PM
	THE LISTING COMMITTEE OF NASDAQ HELSINKI HAS RESOLVED TO DELIST THE SHARES OF BIOTIE THERAPIES CORP. (NASDAQ:ACOR) finance.yahoo.com - August 25 at 8:05 AM
	Acorda Therapeutics Can Deliver Sustained Growth - Seeking Alpha (NASDAQ:ACOR) seekingalpha.com - August 24 at 3:19 PM
	Human Biobanking Ownership Market Analysis and Industry Overview 2016 to 2024 (NASDAQ:ACOR) reports.pr-inside.com - August 24 at 11:35 AM
	Acorda CEO: EpiPen increase 'far in excess' of industry s... (NASDAQ:ACOR) finance.yahoo.com - August 23 at 8:36 PM
	Watch List: China Cord Blood Corporation (NYSE:CO), Acorda Therapeutics, Inc. (NASDAQ:ACOR), Interactive ... - KC Register (NASDAQ:ACOR) www.kcregister.com - August 22 at 8:26 PM
	Will Acorda Therapeutics, Inc. (NASDAQ:ACOR) Hit $60 Price Target? - Investor Newswire (NASDAQ:ACOR) www.investornewswire.com - August 22 at 8:04 AM
	Stock Tracking Lower for the Quarter: Acorda Therapeutics, Inc. (NASDAQ:ACOR) - Post News (NASDAQ:ACOR) www.kentuckypostnews.com - August 21 at 8:04 AM
	Crowd Ratings & Broker Views on Acorda Therapeutics, Inc. (NASDAQ:ACOR)? - Post News (NASDAQ:ACOR) www.kentuckypostnews.com - August 20 at 7:58 AM
	Shares Moving Lower Over the Past Month Acorda Therapeutics, Inc. (NASDAQ:ACOR) - Post News (NASDAQ:ACOR) www.kentuckypostnews.com - August 18 at 3:17 PM
	Biotie Therapies : CORP. APPLIES FOR DELISTING OF ITS SHARES FROM NASDAQ HELSINKI (NASDAQ:ACOR) www.4-traders.com - August 18 at 11:41 AM
	BIOTIE THERAPIES CORP. APPLIES FOR DELISTING OF ITS SHARES FROM NASDAQ HELSINKI (NASDAQ:ACOR) finance.yahoo.com - August 18 at 11:41 AM
	ACORDA THERAPEUTICS INC Financials (NASDAQ:ACOR) finance.yahoo.com - August 12 at 3:18 PM
	Upcoming Earnings Report: Acorda Therapeutics, Inc. (NASDAQ:ACOR) - The Voice Registrar (NASDAQ:ACOR) voiceregistrar.com - August 11 at 3:17 PM

Social

Acorda Therapeutics (NASDAQ:ACOR) Chart for Friday, September, 30, 2016